Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aca152ba4602da5909c80dcbdef46ef5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162 |
filingDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f42f8fca4832605334355de5ce88211 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ab1aaff0d5ace0b537a0b4e32ee7e42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37076047d9e37a74bd9c65d5d536c9d |
publicationDate |
2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019142980-A |
titleOfInvention |
Treatment of addiction and impulse control disorders with PDE7 inhibitors |
abstract |
Provided is a treatment for addiction and impulse control disorders using a PDE7 inhibitor. The present disclosure relates to the treatment of addiction and primary impulse control disorders using phosphodiesterase 7 (PDE7) inhibitors alone or in combination with other therapeutic agents. The present invention determines that a subject has or is at risk of developing addiction, and then administers to the subject a phosphodiesterase 7 (PDE7) inhibitor effective for treating or preventing the addiction Provides a method of treating or preventing addiction. In one aspect of the invention, the subject is addictive to an addictive drug. [Selection] Figure 24D |
priorityDate |
2012-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |